Home/Filings/4/0000950170-24-075038
4//SEC Filing

Meeter Dalen 4

Accession 0000950170-24-075038

CIK 0001850906other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 5:24 PM ET

Size

7.2 KB

Accession

0000950170-24-075038

Insider Transaction Report

Form 4
Period: 2024-06-15
Meeter Dalen
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-06-15+6,250224,523 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-06-156,25068,750 total
    Common Stock (6,250 underlying)
Footnotes (4)
  • [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Includes 3,000 shares acquired under the Issuer's employee stock purchase plan since the Reporting Person last filed a Form 4 with the Securities and Exchange Commission.
  • [F3]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F4]The RSUs vest in 16 equal quarterly installments over four years measured from March 15, 2023.

Documents

1 file

Issuer

Singular Genomics Systems, Inc.

CIK 0001850906

Entity typeother

Related Parties

1
  • filerCIK 0001859032

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 5:24 PM ET
Size
7.2 KB